neotiv Competitors

Lumosity is a leading brain training program, brought to you by Lumos Labs, Inc. Lumosity’s web and mobile games are designed by scientists to challenge core cognitive abilities. Lumosity’s scientists take neuropsychological and cognitive research tasks, or design new ones, and work with game designers to transform them into 50+ cognitive games. Designed to be both fun and adaptively challenging, Lumosity’s training program is accessible to people of all ages — helping them stay challenged to the full extent of their abilities. Lumos Labs also has a collaborative research initiative, the Human Cognition Project, which currently partners with over 90 university collaborators. Through the HCP, we grant qualified researchers free access to Lumosity’s cognitive training tasks, assessments, research tools, and, in some cases, limited access to data on cognitive task performance — helping them conduct larger, faster, and more efficient studies. For more information, please visit http://www.lumosity.com/hcp

BrainCheck is a digital health company powering positive progress in cognitive health. The BrainCheck Platform™ offers the most comprehensive digital cognitive toolset to promote proactive screening, detect early signs of decline, and personalize care planning – anytime, anywhere. Founded by renowned neuroscientists and technologists, including David Eagleman, PhD, our intuitive solutions transcend the limitations of traditional methods and expand access to cognitive care with the tap of a finger, from any device, in any location. Trusted by hundreds of leading providers and healthcare systems, our clinically-validated digital cognitive assessment and care planning tools fit seamlessly into workflows, including EHR integration, delivering actionable insights with ease. Earlier, better, longer brain health begins with empowering action: Don’t raincheck the BrainCheck™. To learn more, visit braincheck.com.

Cognitive health starts here. Neurotrack’s rapid digital cognitive screening can identify patients with cognitive impairment in just 3 minutes. This tool enables clinicians—for the first time ever—to screen and monitor cognitive function as they would any other vital sign. We believe it will increase the number of annual cognitive assessments completed, open the door to meaningful early intervention, improve access to new pharmaceutical treatment options, and validate or alleviate patient concerns. By design, it fits easily within a typical primary care annual wellness visit workflow. It scores instantly and objectively, requires no specialized training to administer, and uses culturally-agnostic symbols and numbers to ensure inclusivity and remove barriers to care. In 40 seconds, a medical assistant can set a patient up to take the screening on a tablet independently in an exam room, then upload results to the EMR. Or patients can be sent a link to take the test remotely and walk in ready to discuss results. As a complement to this first-line screening, Neurotrack offers access to patient education and coaching to support a brain-healthy lifestyle. Neurotrack has published 25 peer-reviewed papers and its solutions have been recognized by leading organizations including the Cleveland Clinic and the National Institute on Aging. Working with providers, health systems and employer partners, Neurotrack has enabled more than 170,000 cognitive assessments on its platform. In February 2023, Neurotrack was named winner of the Alzheimer’s Association Pitch Competition, aimed at identifying innovations to increase cognitive assessment and early detection and diagnosis of dementia within primary care settings. In August 2023, we were named to the Norrsken Impact/100, a list of the world's top impact startups. The company has raised a total of $57 million in funding to support and accelerate its go-to-market push with major health systems and providers.